• Diamond II; Dr. McCearley (persistent atrial fibrillation)
  • AEGIS II: Dr. B. Bennett, Dr. Hays, Dr. Young (post myocardial infarction)
  • CADFEM: Dr. B Bennett, Dr. Hays, G. Bennett
  • Novartis- Paraglide: Dr. Hays (heart failure)
  • Biofourmis- AIM POWER: Dr. B. Bennett (heart failure)
  • MicroPort- Target IV NA: Dr. B. Bennett (coronary stent)
  • Ablative Solutions- Target BP: Dr. G. Bennett, Dr. Crowder (hypertension)
  • Ancora- Corcinch: Dr. Crowder, Dr. G. Bennett (heart failure)
  • Abbott- Catalyst: Dr. Crowder (atrial fibrillation)
  • Abbott-Life BTK: Dr. G.Bennett, Dr. Crowder (Critical Limb Ischemia)
  • Novartis- Inclisiran: Dr. Hays (ACS lipid trial)
  • Novartis- Victorian 2 Prevent; Dr. Hays (lipid trial)
  • Medtronic- Define Afib: Dr. McCearley (atrial fibrillation/LinQ)
All of our currently enrolling studies can be looked up at https://clinicaltrials.gov/